cinoxacin has been researched along with Respiratory Tract Infections in 1 studies
Cinoxacin: Synthetic antimicrobial related to OXOLINIC ACID and NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.
cinoxacin : A member of the class of cinnolines that is 6,7-methylenedioxycinnolin-4(1H)-one bearing an ethyl group at position 1 and a carboxylic acid group at position 3. An analogue of oxolinic acid, it has similar antibacterial actions. It was formerly used for the treatment of urinary tract infections.
Respiratory Tract Infections: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schito, G | 1 |
| Debbia, E | 1 |
1 other study available for cinoxacin and Respiratory Tract Infections
| Article | Year |
|---|---|
[Cinoxacin reduces the diffusion of plasmid resistance to antibiotics].
Topics: Cinoxacin; Drug Resistance, Microbial; Humans; Pyridazines; R Factors; Respiratory Tract Infections | 1987 |